These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004. Cree M, Tonita J, Turner D, Nugent Z, Alvi R, Barss R, King C, Winget M. Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928 [Abstract] [Full Text] [Related]
3. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment. Winget M, Hossain S, Yasui Y, Scarfe A. Cancer; 2010 Oct 15; 116(20):4849-56. PubMed ID: 20578180 [Abstract] [Full Text] [Related]
4. Referral rate to oncologists and its variation by hospital for colorectal cancer patients. Kreiter E, Yasui Y, de Gara C, White J, Winget M. Ann Surg Oncol; 2012 Mar 15; 19(3):714-21. PubMed ID: 21922337 [Abstract] [Full Text] [Related]
5. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Lima IS, Yasui Y, Scarfe A, Winget M. Cancer; 2011 Aug 15; 117(16):3833-40. PubMed ID: 21319156 [Abstract] [Full Text] [Related]
8. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature]. Mátrai Z, Lövey J, Hitre E, Orosz Z, Gödény M, Péley G, Sulyok Z, Rényi Vámos F, Farkas E, Köves I. Orv Hetil; 2006 Oct 22; 147(42):2011-20. PubMed ID: 17165600 [Abstract] [Full Text] [Related]
10. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center. Deo S, Kumar S, Shukla NK, Kar M, Mohanti BK, Sharma A, Raina V, Rath GK. Indian J Cancer; 2004 Oct 22; 41(3):120-4. PubMed ID: 15472410 [Abstract] [Full Text] [Related]
11. Patterns of chemotherapy use for women with ovarian cancer: a population-based study. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL. J Clin Oncol; 2003 Apr 15; 21(8):1530-5. PubMed ID: 12697877 [Abstract] [Full Text] [Related]
12. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009. Cho MM, Morgan JW, Knutsen R, Oda K, Shavlik D, Knutsen S, Kazanjian K. Dis Colon Rectum; 2013 Dec 15; 56(12):1357-65. PubMed ID: 24201389 [Abstract] [Full Text] [Related]
18. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer. Luna-Pérez P, Reyna Huelga A, Labastida Almendaro S, Rodríguez-Coria DF, González Macouzet J, Delgado Gallardo S. Rev Invest Clin; 1999 Aug 01; 51(4):205-13. PubMed ID: 10546501 [Abstract] [Full Text] [Related]
19. Predictors of surgery and consult with an oncologist for adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada. Winget M, Stanger J, Gao Z, Butts C. J Thorac Oncol; 2009 May 01; 4(5):629-34. PubMed ID: 19276835 [Abstract] [Full Text] [Related]